Biomedical Engineering Reference
In-Depth Information
11. OVRUM E, TANGEN G, OYSTESE R, RINGDAL MAL, ISTAD R (2001), 'Comparison of
two heparin coated extracorporeal circuits with reduced systemic anticoagula-
tion in routine coronary artery bypass operations',
J Thorac Cardiovasc Surg
,
121
, 324-330.
12. VIDEM V, MOLLNES TE, FOSSE E
et al.
(1999) , 'Heparin coated cardiopulmonary
bypass equipment: biocompatibility markers and development of complications
in a high risk population',
J Thorac Cardiovasc Surg
,
117
, 794-802.
13. GUNAYDIN S (2004), 'Emerging technologies in biocompatible surface modifying
additives: quest for physiologic cardiopulmonary bypass',
Curr Med Chem Car-
diovascular & Hematologic Agents
,
2
, 187-196.
14. GUNAYDIN S, MCCUSKER K, VIJAY V (2005), 'Clinical performance and biocompat-
ibility of novel hyaluronan-based heparin-bonded extracorporeal circuits',
J Extra Corpor Technol
,
37
(3), 290-295.
15. GUNAYDIN S, FARSAK B, KOCAKULAK M, SARI T, YORGANCIOGLU C,
ZORLUTUNA Y (2002), 'Clinical performance and biocompatibility of poly(2-
methoxyethylacrylate) coated extracorporeal circuits',
Ann Thorac Surg
,
74
(3),
819-824.
16. GUNAYDIN S (2004), 'Clinical signifi cance of coated extracorporeal circuits: a
review of novel technologies',
Perfusion
,
19
, S33-S41.
17. GUNAYDIN S, MCCUSKER K, VIJAY V
et al.
(2006), 'Comparison of polymethoxyeth-
ylacrylate-coated circuits with leukocyte fi ltration and reduced heparinization
protocol on heparin-bonded circuits in different risk cohorts',
Perfusion
,
21
(6),
329-342.
18. SOCIETY OF THORACIC SURGEONS BLOOD CONSERVATION GUIDELINE TASK FORCE,
FERRARIS VA, FERRARIS SP, SAHA SP
et al.
(2007), 'Perioperative blood transfusion
and blood conservation in cardiac surgery: the Society of Thoracic Surgeons
and The Society of Cardiovascular Anesthesiologists clinical practice guideline',
Ann Thorac Surg
,
83
(5 Suppl), S27-86.
19. MULHOLLAND JW, ANDERSON JR, YARHAM GJ, TULADHUR S, SAED I, OLIVER MD (2007),
'Miniature cardiopulmonary bypass - the Hammersmith experience',
Perfusion
,
22
, 161-166. DOI: 10.1177/0267659107076880.
20. KUTSCHKA I, SCHÖNROCK U, EL ESSAWI A, PAHARI D, ANSSAR M, HARRINGER W (2007),
'A new minimized perfusion circuit provides highly effective ultrasound con-
trolled deairing',
Artifi cial Organs
,
31
(3), 215-220.
21. GUNAYDIN S, AYRANCIOGLU K, DIKMEN E
et al.
(2007), 'Clinical effects of leukofi l-
tration and surface modifi cation on post-cardiopulmonary bypass atrial fi brilla-
tion in different risk cohorts',
Perfusion
,
22
(4), 279-288.
22. GUNAYDIN S, MCCUSKER K, VIJAY V (2005), 'Strategic leukofi ltration in cardiac
surgery',
Curr Med Chem
,
3
, 173-179.
23. GUNAYDIN S, SARI T, MCCUSKER K
et al.
(2005), 'Clinical evaluation strategic
leukofi ltration with surface modifi cation: enhanced preservation or fantasy',
Filtration
,
1
(1), 57-67.
24. GUNAYDIN S, MCCUSKER K, VIJAY V
et al.
(2005), 'Clinical signifi cance of strategic
leukocyte fi ltration in different risk cohorts undergoing cardiac surgery',
Filtra-
tion
,
1
(2), 95-106.
Search WWH ::
Custom Search